Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 297

Similar articles for PubMed (Select 11435451)

1.

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Tilley SL, Coffman TM, Koller BH.

J Clin Invest. 2001 Jul;108(1):15-23. Review. No abstract available.

2.

Prostaglandins in inflammation and disease.

Ninnemann JL.

Immunol Today. 1984 Jun;5(6):173-5. doi: 10.1016/0167-5699(84)90011-2. No abstract available.

PMID:
25289746
3.

The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity.

Harizi H.

Biomed Res Int. 2013;2013:683405. doi: 10.1155/2013/683405. Epub 2013 Aug 20. Review.

4.

Neural circuitry engaged by prostaglandins during the sickness syndrome.

Saper CB, Romanovsky AA, Scammell TE.

Nat Neurosci. 2012 Jul 26;15(8):1088-95. doi: 10.1038/nn.3159. Review.

5.

Prostaglandins and inflammation.

Ricciotti E, FitzGerald GA.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000. doi: 10.1161/ATVBAHA.110.207449. Review.

6.

Smoking-induced nociception.

Smith HS.

Pain Physician. 2011 Jan-Feb;14(1):E1-4. No abstract available.

7.

Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology.

Honda T, Tokura Y, Miyachi Y, Kabashima K.

Curr Drug Targets. 2010 Dec;11(12):1605-13. Review.

PMID:
20735353
8.

Prostanoids and inflammation: a new concept arising from receptor knockout mice.

Narumiya S.

J Mol Med (Berl). 2009 Oct;87(10):1015-22. doi: 10.1007/s00109-009-0500-1. Epub 2009 Jul 17. Review.

PMID:
19609495
9.

Resolving the problem of persistence in the switch from acute to chronic inflammation.

Haworth O, Buckley CD.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20647-8. Epub 2007 Dec 18. No abstract available.

10.

Prostaglandins: mediators of inflammation?

Marx JL.

Science. 1972 Sep 1;177(4051):780-1. No abstract available.

PMID:
17840126
11.

Anti-inflammatory drugs in the 21st century.

Rainsford KD.

Subcell Biochem. 2007;42:3-27. Review.

PMID:
17612044
12.

Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.

Botting RM.

J Physiol Pharmacol. 2006 Nov;57 Suppl 5:113-24. Review.

13.

Getting to the heart of COX-2 inhibition.

Breyer MD.

Cell Metab. 2005 Sep;2(3):149-50.

14.

Dual inhibition of cyclo-oxygenases and 5-lipoxygenase: a novel therapeutic approach to inflammation?

Naveau B.

Joint Bone Spine. 2005 May;72(3):199-201. No abstract available.

PMID:
15850989
15.

New insights into COX-2 biology and inhibition.

Patrignani P, Tacconelli S, Sciulli MG, Capone ML.

Brain Res Brain Res Rev. 2005 Apr;48(2):352-9. Review.

PMID:
15850674
16.

Localized vs. systemic inflammation in guinea pigs: a role for prostaglandins at distinct points of the fever induction pathways?

Rummel C, Barth SW, Voss T, Korte S, Gerstberger R, Hübschle T, Roth J.

Am J Physiol Regul Integr Comp Physiol. 2005 Aug;289(2):R340-R347. Epub 2005 Apr 14.

17.

[Role of prostaglandins in rheumatoid arthritis].

Masuko-Hongo K.

Nihon Rinsho. 2005 Jan;63 Suppl 1:136-9. Review. Japanese. No abstract available.

PMID:
15799333
18.

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.

Minghetti L.

J Neuropathol Exp Neurol. 2004 Sep;63(9):901-10. Review.

PMID:
15453089
19.

[Therapeutic advances with coxibs: few certainties and a lot of doubts].

Jouzeau JY, Daouphars M, Netter P.

Therapie. 2004 Mar-Apr;59(2):207-11. Review. French. No abstract available.

PMID:
15359614
20.

[The controversy surrounding the coxibs: the first report].

Maigret P.

Therapie. 2004 Mar-Apr;59(2):199. French. No abstract available.

PMID:
15359613
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk